CClinicalTrials.gg
Status unknownNCT05355740SUPEM1Updated Mar 30, 2023

The Effect of Post-surgical Chlorhexidine Mouth Washing on the Sub-gingival Periodontal Microbiome A Pilot Study

An observational study in Periodontitis and Subgingival Plaque, sponsored by Rambam Health Care Campus. Status unknown at 2 sites in Israel. Open to participants aged 18 Years to 99 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-03-30.

Sponsored by Rambam Health Care Campus · Observational

The sponsor has not verified this record recently (last verified Mar 2023), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
30
Ages
18 Years to 99 Years
Sex
All
01

Study summary

Prospective applicants who conform with inclusion and exclusion criteria will be accepted into the study and sign a consent form.

Visit 1: After initial screening a case report form (CRF) will be filled, including information regarding general health, medication, demographic, oral and dental information. Participants will be clinically examined and the following data will be collected prior to surgery: microbial collection, Plaque score (PS) , probing pocket depth (PPD), bleeding on probing (BOP) at selected non-surgical and surgical teeth. Surgery will be performed followed by discharge with a bottle of chlorhexidine mouthwash and written instructions on its usage. Visit 2: Ten days after surgery sutures will be removed and collected for microbial examination. Microbial collection will be performed at non-surgical and surgical sites. Adverse events will be recorded and participants will be discharged from the study.

Read the detailed description

Microbial identification: periodontal samples will be collected by the GeneFiX™ Saliva DNA Microbiome Collection Device (Isohelix). DNA Extraction - the MagMAX Microbiome Ultra Nucleic Acid Isolation Kits (Termo Fisher). DNA yields and purity - measuring absorbance at 260 nm, A260/A280 and A260/A230 ratios with the Nano-drop 2000 spectrophotometer (Nanodrop products, Wilmigton,USA). Microbiome sequencing - target V4 region of 16s rRNA gene will be sequenced on the Ion Torrent S5 instrument (Thermofisher) and analysis will be performed with the ERGO 2.0 platform ( iGenbio). The investigators will perform comparisons of alpha and beta diversity before and after intervention, as well as differential abundance of the taxa.

02

Conditions studied

  • Periodontitis
  • Subgingival Plaque

Browse trials for

Keywords

  • chlorhexidine
  • subgingival plaque
03

In context

Periodontitis

1,635 studies on the registry are indexed under Periodontitis; 327 are open to participants now.

This study's planned enrollment of 30 is below the median of 90 across 428 observational studies indexed under Periodontitis.

Browse Periodontitis studies →

Lead sponsor

Rambam Health Care Campus is the lead sponsor of 456 studies on the registry; 33 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients scheduled for periodontal surgery/dental extractions at the Rambam Department of Periodontology

Inclusion criteria

  • Signed Informed Consent Form
  • Age ≥18 years
  • Scheduled for periodontal/dental surgery without pre- and/or post-surgical antibiotic therapy

Exclusion criteria

Exclusion Criteria:

  • Pre-existing conditions that may affect the microbiome, including diagnoses of diabetes, malignancy, alcoholism, previous head and neck radiation therapy
  • Pregnancy and breast-feeding
  • Chronic medications that are known to affect periodontal tissues such as Ca channel blockers and phenytoin
  • Antibiotic therapy within the previous 6 weeks
  • Mouthwash therapy within the previous 2 weeks
  • Known allergy to CM or any of its constituents
  • Smoking >10 cigarettes/day
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
30 participants (estimated)
Patient registry
No

Interventions

  • DrugCorsodyl

    Corsodyl (a chlorhexidine mouthwash) will be used to rinse the mouth for one minute with 10 ml twice daily during ten days after oral surgery

    Also known as: Chlorhexidine mouthwash

06

What researchers measure

Primary outcomes

  1. alpha and beta diversity

    sub-gingival microbiome changes between pre- and post- mouthwash usage in non-surgical sites and in surgical sites

    Time frame: 10-14 days

07

Study locations

2 of 2 sites recruiting
  • Rambam Health Care Campus
    Haifa, 3109601, Israel
    Recruiting
  • Rambam Health Care Campus
    Haifa, 31096, Israel
    • Jacob Horwitz, DMD · Contact · 972-4-854-2983
    • Jacob Horwitz, DMD · Principal investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 30, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05355740
Lead sponsor
Rambam Health Care Campus
Responsible party
Jacob Horwitz MD (Director-Graduate Program in Periodontology, Rambam Health Care Campus) — Principal investigator
First posted
May 2, 2022
Start date
Feb 3, 2023
Primary completion
Jun 10, 2024 (estimated)
Completion
Jun 25, 2024 (estimated)
Last update
Mar 30, 2023

Study contacts

Liron Eliezer
Contact
l_eliezer@rambam.health.gov.il
+972 4 7772983
Jacob Horwitz, DMD
Contact
j_horwitz@rambam.health.gov.il
+972 4 7772983
Jacob Horwitz, DMD
principal investigator · Rambam Health Care Campus

Oversight

FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion